Pershing Square Sohn Cancer Research Alliance Back to Lessons Learned

It's about more than money

Pershing Square Sohn Cancer Research Alliance

Mission

The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Perhaps the best illustration of the power of The Pershing Square Foundation community comes from the Pershing Square Sohn Cancer Research Alliance (PSSCRA). In 2013, PSSCRA created the Pershing Square Sohn Prize for Young Investigators in Cancer Research to provide young, New York-based scientists the freedom to take risks and pursue bold research at a stage in their careers when traditional funding is lacking. Prize winners each receive $200,000 a year for three years for innovative research that is typically too risky for the support of the National Institutes of Health. In pursuit of cures, PSSCRA facilitates collaborations between science and business, linking academic research with the pharmaceutical and biotech industries. Through its Advisory Board, Scientific Review Council, regular convenings, and formal and informal mentorship programs, PSSCRA has created a strong cross-sector community of thinkers and doers focused on the life sciences – and on encouraging life-saving medical breakthroughs.

The Pershing Square Sohn Cancer Research Alliance - Overview and impact